Abdominal lymphadenopathy in children with AIDS.

Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Abdominal lymphadenopathy in children with AIDS.

Pediatr AIDS HIV Infect. 1994 Oct;5(5):305-8. Unique Identifier : AIDSLINE AIDS/95330395
Chung CJ; Sivit CJ; Rakusan TA; Ellaurie M; Department of Diagnostic Imaging and Radiology, Children's; National Medical Center, Washington, DC, USA.

Abstract: PURPOSE. To identify conditions associated with abdominal lymphadenopathy in children with vertically-transmitted human immunodeficiency virus (HIV) infection. METHODS. Abdominal computed tomography (CT) scans were performed on 29 children over an eight-year period. The presence or absence of abdominal lymphadenopathy (> 10 mm in diameter) was prospectively evaluated at the time of CT. Clinical and histopathologic data in these children was reviewed. RESULTS. Abdominal lymphadenopathy was noted in eight (28%) children. The lymphadenopathy was isoattenuating relative to adjacent muscle in all cases. The most common specific associated diagnosis was systemic infection with Mycobacterium avium intracellulare (three children). One child had disseminated Kaposi sarcoma while four children had no known associated systemic infection or neoplasm. CONCLUSIONS. Abdominal lymphadenopathy was noted at CT in 28% of all HIV-infected children studied with CT and represented a nonspecific finding. The presence of lymphadenopathy should raise the suspicion of disseminated mycobacterial infection; however, it may also be observed in the absence of known systemic infection or neoplasm.

Keywords: Abdomen/RADIOGRAPHY Acquired Immunodeficiency Syndrome/*COMPLICATIONS/RADIOGRAPHY/ TRANSMISSION Child Child, Preschool Disease Transmission, Vertical Female Human Infant Lymphatic Diseases/*COMPLICATIONS/RADIOGRAPHY Male Prospective Studies Tomography, X-Ray Computed JOURNAL ARTICLE
951030
M95A0915

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .